October 18, 2008 3:29 PM
- Text
Teva Joins Bizarre Drug-Based Game Trend
(MoneyWatch) In what is turning out to be an increasingly strange fad among drug companies, Teva, the generics giant, has produced an online game titled "Biologicsland." Some have noted it looks a lot like Candyland.
Regular BNET readers will remember that Sanofi-Aventis, Pfizer and Novo Nordisk have all waded into the online and video game sphere, with what I will diplomatically describe as varying degrees of success. (Continues below game image.)
So how does Teva's Biologicsland compare? Users choose to play as a scientist, lobbyist, professor, politician or doctor. They then proceed around the board answering multiple choice questions for points. The questions are hardly riveting:
I played as a lobbyist and, by the end of the game, realized I was being not-so-subtly pitched on the idea of creating a legal generic pathway for biologics. Not surprising, given that Teva cannot current sell generic biologics but obviously wants to.
Even though there are only eight questions, you'll be dying of boredom by the end of it.
Regular BNET readers will remember that Sanofi-Aventis, Pfizer and Novo Nordisk have all waded into the online and video game sphere, with what I will diplomatically describe as varying degrees of success. (Continues below game image.)
So how does Teva's Biologicsland compare? Users choose to play as a scientist, lobbyist, professor, politician or doctor. They then proceed around the board answering multiple choice questions for points. The questions are hardly riveting:
In 2006, the federal government spent how much to purchase biologics medicines?I'll give you a freebie: The answer is $40 billion. Get the question wrong, however, and a cloud of cell-like monsters with teeth invade the screen, followed by a trippy Twilight Zone-style death spiral, before the player is invited to find out the correct answer.
I played as a lobbyist and, by the end of the game, realized I was being not-so-subtly pitched on the idea of creating a legal generic pathway for biologics. Not surprising, given that Teva cannot current sell generic biologics but obviously wants to.
Even though there are only eight questions, you'll be dying of boredom by the end of it.
Latest Now in MoneyWatch
- Insurers respond cautiously to contraceptive plan
- Judge: Legally, breastfeeding not related to pregnancy
- Budget deficit drops to $27 billion in January
- Why the Powerball Jackpot is part of my investment strategy
- Is the new VW Beetle diesel worth the money?
- Consumer sentiment highlights risks to recovery
- Valentine blues? 10 best cities to be single
- December trade deficit widens to $48.8 billion
- Alcatel-Lucent returns to profit in 2011
- 6 things never to say in a performance review
- $26B mortgage deal: Who gets the money?
- Friendly's CEO steps down
- Quarterly loss hits $3.3B at Postal Service
- Greeks rail against cuts as EU demands more
- 6 things you should never share on Facebook
- Make moves now to increase financial aid
- Valentine's Day: 9 places to save
Latest CBS News Headlines
on Facebook
on CBS News
- NYC artist recognized for his unique beeswax art
- Ga. county buys late folk artist's Paradise Garden
- Katy Perry, Russell Brand finalize divorce
- Katy Perry, Russell Brand finalize divorce
on Facebook
- Adele sings a cappella for Anderson Cooper
- Josh Powell had "incestuous" images on his home computer, authorities say
- Adele sings a cappella for Anderson Cooper
on CBS News






